All posts tagged
French Biotech Gets a CRISPR Patent for CAR-T Research
Why Does Europe Lag Behind the US and China in the Gene Editing Race?
Biotech and Pharma Boost R&D and Slow Sales to Beat Antibiotic Resistance
Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?
European Court Supports the Softening of CRISPR Gene Editing Rules
Interview: Why Asian CROs are Turning to the European Biotech Market
Dutch Cancer Nanoparticles Get €2.5M from the EU to Enter Phase II
The EU Gives €6.3M Grant to Anti-Cancer Consortium
Welcome to Amsterdam, EMA! Your New Home Post-Brexit
Thinking of Leaving Academia? Read this VC Partner’s Story
Where is the Money Going in Biotech? A Peek into European VC Strategy
Get your Company Ready for the EU’s New Data Protection Law
Labiotech UG, All Rights Reserved -
Send this to a friend